Metraipolis › archive › dc_7818f5bfec01
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm… — Europe PMC PMID:42404549
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42404549
- DOI
- 10.1016/j.esmogo.2025.100270
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T23:46:40.275Z
- SHA-256 of the archived text
7b4875e19d1b7d867d7403f67127a8ab150f01a458e63255c1f19ae51d76a004- Stable URL of this page
https://metraipolis.com/documento/dc_7818f5bfec01
How to cite
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm… — Europe PMC PMID:42404549 — Europe PMC (en), https://europepmc.org/article/MED/42404549 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7818f5bfec01 (Metraipolis archive dc_7818f5bfec01, sha256 7b4875e19d1b7d867d7403f67127a8ab150f01a458e63255c1f19ae51d76a004)
BibTeX
@misc{dc7818f5bfec01,
title = {Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm… — Europe PMC PMID:42404549},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42404549},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7818f5bfec01; sha256 7b4875e19d1b7d867d7403f67127a8ab150f01a458e63255c1f19ae51d76a004},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42404549. Agents can read the archived copy with the MCP tool read_document.